ANXA5 and cholangiocarcinoma: They purified AnnexinV+,EpCAM+ CD147+ EVs from patients with HCC and Cholangiocarcinoma (CCA) (n = 127), with liver cirrhosis (n = 54), and negative controls (n = 202).